Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$22.28 - $38.71 $7,798 - $13,548
-350 Reduced 3.38%
10,000 $307,000
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $80,370 - $121,471
2,350 Added 29.38%
10,350 $354,000
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $23,140 - $49,680
1,000 Added 14.29%
8,000 $277,000
Q1 2022

May 13, 2022

BUY
$27.77 - $64.4 $166,620 - $386,400
6,000 Added 600.0%
7,000 $308,000
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $54,900 - $105,210
1,000 New
1,000 $63,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Water Island Capital LLC Portfolio

Follow Water Island Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Water Island Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Water Island Capital LLC with notifications on news.